TNDM Tandem Diabetes Care Inc

Price (delayed)

$122.43

Market cap

$7.72B

P/E Ratio

1,020.25

Dividend/share

N/A

EPS

$0.12

Enterprise value

$7.94B

Tandem Diabetes Care is a public US medical device manufacturer based in San Diego, CA. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy. ...

Highlights
Tandem Diabetes Care's EPS has soared by 131% from the previous quarter and by 117% YoY
The net income has soared by 127% from the previous quarter and by 116% YoY
The debt has increased by 43% YoY

Key stats

What are the main financial stats of TNDM
Market
Shares outstanding
63.03M
Market cap
$7.72B
Enterprise value
$7.94B
Valuations
Price to earnings (P/E)
1,020.25
Price to book (P/B)
22.16
Price to sales (P/S)
12.69
EV/EBIT
412.83
EV/EBITDA
243.69
EV/Sales
13.12
Earnings
Revenue
$604.84M
EBIT
$19.22M
EBITDA
$32.56M
Free cash flow
$71.19M
Per share
EPS
$0.12
Free cash flow per share
$1.14
Book value per share
$5.53
Revenue per share
$9.64
TBVPS
$12.68
Balance sheet
Total assets
$795.25M
Total liabilities
$449.17M
Debt
$317.24M
Equity
$346.09M
Working capital
$589.56M
Liquidity
Debt to equity
0.92
Current ratio
6.42
Quick ratio
5.75
Net debt/EBITDA
6.71
Margins
EBITDA margin
5.4%
Gross margin
53.2%
Net margin
1.1%
Operating margin
3.3%
Efficiency
Return on assets
0.9%
Return on equity
1.9%
Return on invested capital
2.4%
Return on capital employed
2.8%
Return on sales
3.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TNDM stock price

How has the Tandem Diabetes Care stock price performed over time
Intraday
-0.54%
1 week
-0.19%
1 month
10.01%
1 year
14.65%
YTD
27.96%
QTD
25.7%

Financial performance

How have Tandem Diabetes Care's revenue and profit performed over time
Revenue
$604.84M
Gross profit
$321.61M
Operating income
$19.85M
Net income
$6.56M
Gross margin
53.2%
Net margin
1.1%
The operating income has soared by 167% YoY
The operating margin has soared by 146% YoY
The net income has soared by 127% from the previous quarter and by 116% YoY
The net margin has soared by 124% from the previous quarter and by 111% YoY

Growth

What is Tandem Diabetes Care's growth rate over time

Valuation

What is Tandem Diabetes Care stock price valuation
P/E
1,020.25
P/B
22.16
P/S
12.69
EV/EBIT
412.83
EV/EBITDA
243.69
EV/Sales
13.12
Tandem Diabetes Care's EPS has soared by 131% from the previous quarter and by 117% YoY
The company's equity rose by 29% YoY and by 10% QoQ
TNDM's price to book (P/B) is 22% more than its last 4 quarters average of 18.2
The P/S is 57% higher than the 5-year quarterly average of 8.1 and 6% higher than the last 4 quarters average of 12.0
TNDM's revenue is up by 47% year-on-year and by 12% since the previous quarter

Efficiency

How efficient is Tandem Diabetes Care business performance
Tandem Diabetes Care's ROS has soared by 132% YoY
TNDM's ROE has soared by 125% from the previous quarter and by 109% YoY
The return on assets has surged by 125% since the previous quarter and by 108% year-on-year
The return on invested capital has surged by 116% year-on-year

Dividends

What is TNDM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TNDM.

Financial health

How did Tandem Diabetes Care financials performed over time
The total assets is 77% greater than the total liabilities
Tandem Diabetes Care's quick ratio has increased by 40% YoY
TNDM's current ratio is up by 36% year-on-year
The debt is 8% less than the equity
The debt has increased by 43% YoY
The company's equity rose by 29% YoY and by 10% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.